β¨ Medicines and Health Board Appointments
NEW ZEALAND GAZETTE, No. 38 β 16 APRIL 2015
Product:
Difflam Anaesthetic, Anti-Inflammatory & Antibacterial Sugar Free Blackcurrant
Active Ingredients:
Benzydamine hydrochloride 3mg
Dichlorobenzyl alcohol 1.2mg
Lidocaine hydrochloride 4mg
Dosage Form:
Lozenge
New Zealand Sponsor:
iNova Pharmaceuticals (New Zealand) Limited
Manufacturer:
Unique Pharmaceuticals Laboratories, Nani Daman, India
Product:
Difflam Anaesthetic, Anti-Inflammatory & Antibacterial Sugar Free Honey & Lemon
Active Ingredients:
Benzydamine hydrochloride 3mg
Dichlorobenzyl alcohol 1.2mg
Lidocaine hydrochloride 4mg
Dosage Form:
Lozenge
New Zealand Sponsor:
iNova Pharmaceuticals (New Zealand) Limited
Manufacturer:
Unique Pharmaceuticals Laboratories, Nani Daman, India
Dated this 9th day of April 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go2203
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Avastin
Active Ingredient:
Bevacizumab 25mg/mL
Dosage Form:
Concentrate for infusion
New Zealand Sponsor:
Roche Products (NZ) Limited
Manufacturers:
Genentech Inc, California, United States of America
F Hoffmann-La Roche Limited, Basel, Switzerland
Roche Diagnostics GmbH, Mannheim, Germany
F Hoffmann-La Roche Limited, Kaiseraugst, Switzerland
Product:
Ozurdex
Active Ingredient:
Dexamethasone 700mcg
Dosage Form:
Intraocular implant
New Zealand Sponsor:
Allergan New Zealand Limited
Manufacturer:
Allergan Pharmaceuticals Ireland, County Mayo, Ireland
Product:
Robinul
Active Ingredient:
Glycopyrronium bromide 0.2mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers:
Hameln Pharmaceuticals GmbH, Hameln, Germany
Biologici Italia Laboratories Srl, Milan, Italy
Dated this 9th day of April 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go2204
Appointments to the Nelson Marlborough District Health Board
Pursuant to section 28(1)(a) of the Crown Entities Act 2004, the Minister of Health has appointed
Russell Wilson
44
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare9 April 2015
Medicines Act 1981, New Medicines, Distribution, Difflam, Avastin, Ozurdex, Robinul
- SARAH READER, Acting Group Manager, Medsafe, Ministry of Health
π₯ Appointments to the Nelson Marlborough District Health Board
π₯ Health & Social WelfareCrown Entities Act 2004, Health Board, Appointments, Nelson Marlborough
- Russell Wilson, Appointed to Nelson Marlborough District Health Board
NZ Gazette 2015, No 38